A survey of attitudes about maternal serum screening for fetal chromosome abnormalities in women 35 years of age and older

Owen Phillips, Linda Seely, Jim Wan, Stephen S. Wachtel, Lee P. Shulman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling) for advanced maternal age (≥ 35 years) and group 2 women who had undergone MSS and were 30-34 years old. Women in group 1 were found significantly less likely to choose MSS over prenatal diagnosis than were women in group 2. The sensitivity of MSS and the age-related risk of chromosome abnormalities influenced opinions on whether to choose MSS or prenatal diagnosis. In both groups, the majority stated that they would accept MSS over prenatal diagnosis, if their obstetrician recommended it.

Original languageEnglish (US)
Pages (from-to)357-360
Number of pages4
JournalFetal Diagnosis and Therapy
Volume13
Issue number6
DOIs
StatePublished - Dec 1 1998

Fingerprint

Chromosome Aberrations
Mothers
Prenatal Diagnosis
Serum
Chorionic Villi Sampling
Amniocentesis
Maternal Age
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

A survey of attitudes about maternal serum screening for fetal chromosome abnormalities in women 35 years of age and older. / Phillips, Owen; Seely, Linda; Wan, Jim; Wachtel, Stephen S.; Shulman, Lee P.

In: Fetal Diagnosis and Therapy, Vol. 13, No. 6, 01.12.1998, p. 357-360.

Research output: Contribution to journalArticle

@article{cb7c8370b9c64e52807b591c160baad6,
title = "A survey of attitudes about maternal serum screening for fetal chromosome abnormalities in women 35 years of age and older",
abstract = "We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling) for advanced maternal age (≥ 35 years) and group 2 women who had undergone MSS and were 30-34 years old. Women in group 1 were found significantly less likely to choose MSS over prenatal diagnosis than were women in group 2. The sensitivity of MSS and the age-related risk of chromosome abnormalities influenced opinions on whether to choose MSS or prenatal diagnosis. In both groups, the majority stated that they would accept MSS over prenatal diagnosis, if their obstetrician recommended it.",
author = "Owen Phillips and Linda Seely and Jim Wan and Wachtel, {Stephen S.} and Shulman, {Lee P.}",
year = "1998",
month = "12",
day = "1",
doi = "10.1159/000020869",
language = "English (US)",
volume = "13",
pages = "357--360",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - A survey of attitudes about maternal serum screening for fetal chromosome abnormalities in women 35 years of age and older

AU - Phillips, Owen

AU - Seely, Linda

AU - Wan, Jim

AU - Wachtel, Stephen S.

AU - Shulman, Lee P.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling) for advanced maternal age (≥ 35 years) and group 2 women who had undergone MSS and were 30-34 years old. Women in group 1 were found significantly less likely to choose MSS over prenatal diagnosis than were women in group 2. The sensitivity of MSS and the age-related risk of chromosome abnormalities influenced opinions on whether to choose MSS or prenatal diagnosis. In both groups, the majority stated that they would accept MSS over prenatal diagnosis, if their obstetrician recommended it.

AB - We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling) for advanced maternal age (≥ 35 years) and group 2 women who had undergone MSS and were 30-34 years old. Women in group 1 were found significantly less likely to choose MSS over prenatal diagnosis than were women in group 2. The sensitivity of MSS and the age-related risk of chromosome abnormalities influenced opinions on whether to choose MSS or prenatal diagnosis. In both groups, the majority stated that they would accept MSS over prenatal diagnosis, if their obstetrician recommended it.

UR - http://www.scopus.com/inward/record.url?scp=0032429737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032429737&partnerID=8YFLogxK

U2 - 10.1159/000020869

DO - 10.1159/000020869

M3 - Article

VL - 13

SP - 357

EP - 360

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 6

ER -